Alistair Cook - Concepedia

Author

Alistair Cook

The University of Western Australia ORCID

Also Known As

A. Cook, A.M. Cook, ALISTAIR M. COOK, Alistair Cook, Alistair M Cook, Alistair M. Cook, Alistair M. Cook, Cook Alistair, Cook, A, Cook, Alistair M.

Publications

951

Citations

H-Index

Concepts

All Affiliations

The University of Western Australia Sir Charles Gairdner Hospital Asbestos Diseases Research Institute Institute for Respiratory Health The University of Sydney

About

Alistair Cook is an author at The University of Western Australia specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	315
2	Immunology	2	2	134
3	Allergy	1	1	36
4	Anesthesia	1	1	12
5	Emergency Medicine	1	1	12

Alistair Cook

Publications

605

Citations

H-Index

Page 1

	Year	Citations
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in Anna K. Nowak, W. Joost Lesterhuis, Peey‐Sei Kok, The Lancet Oncology Surgical OncologyMalignant Pleural MesotheliomaMedicinePathologyPleural Disease	2020	169
Identification of a Bipotent Epithelial Progenitor Population in the Adult Thymus Svetlana Ulyanchenko, Kathy E. O’Neill, Tanya L. Medley, Cell Reports	2016	119
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma Anna K. Nowak, Alistair Cook, Alison M. McDonnell, Annals of Oncology Phase 1BMalignant Pleural MesotheliomaMedicineCd40-activating Antibody Cp-870,893Immunology	2015	98
Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies Alistair Cook, Alison M. McDonnell, Richard Lake, OncoImmunology	2015	75
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment Wayne J. Aston, Danika E. Hope, Alistair Cook, OncoImmunology Cancer ImmunosurveillanceAllergyPeripheral Blood LymphocytesMedicineDifferent Strains	2019	36
Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial Peey‐Sei Kok, Patrick M. Forde, Brett Hughes, BMJ Open	2022	28
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors Sarah Dart, Alistair Cook, Michael Millward, Scientific Reports	2021	24
Older Patients Are Immunocompromised by Cytokine Depletion and Loss of Innate Immune Function After HIP Fracture Surgery Alasdair Sutherland, Alistair Cook, Clare Miller, Geriatric Orthopaedic Surgery & Rehabilitation	2015	17
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors Jonathan Chee, Mark Watson, Abha Chopra, BMC Research Notes	2018	15
A Survey of Methohexitone Use by Anesthetists in the Clinical Practice of ECT in Edinburgh Alistair Cook, Gary Stevenson, Allan Scott Journal of Ect Consecutive SeriesAnaesthetic AgentPsychiatryPatient SafetyElectroconvulsive Therapy	2000	12

Page 1